BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Diagnosis
10 results:

  • 1. Expression and clinical value of cxcr4 in high grade gastroenteropancreatic neuroendocrine neoplasms.
    Pang C; Li Y; Shi M; Fan Z; Gao X; Meng Y; Liu S; Gao C; Su P; Wang X; Zhan H
    Front Endocrinol (Lausanne); 2024; 15():1281622. PubMed ID: 38524630
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Circulating MiR-1290 as a potential diagnostic and disease monitoring biomarker of human gastrointestinal tumors.
    Xu L; Cai Y; Chen X; Zhu Y; Cai J
    BMC Cancer; 2021 Sep; 21(1):989. PubMed ID: 34479528
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Specific Receptors for the Chemokines CXCR2 and cxcr4 in pancreatic cancer.
    Litman-Zawadzka A; Łukaszewicz-Zając M; Gryko M; Kulczyńska-Przybik A; Kędra B; Mroczko B
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867211
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Wnt/β-catenin signaling as an emerging potential key pharmacological target in cholangiocarcinoma.
    Zhang GF; Qiu L; Yang SL; Wu JC; Liu TJ
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32140709
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. cxcr4/Let-7a Axis Regulates Metastasis and Chemoresistance of pancreatic cancer Cells Through Targeting HMGA2.
    Xiao G; Wang X; Yu Y
    Cell Physiol Biochem; 2017; 43(2):840-851. PubMed ID: 28954272
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Protocol of the PANCALYZE trial: a multicenter, prospective study investigating the tumor biomarkers cxcr4, SMAD4, SOX9 and IFIT3 in patients with resected pancreatic adenocarcinoma to predict the pattern of recurrence of the disease.
    Popp FC; Popp MC; Zhao Y; Betzler C; Kropf S; Garlipp B; Benckert C; Kalinski T; Lippert H; Bruns CJ
    BMC Cancer; 2017 Mar; 17(1):229. PubMed ID: 28356064
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. pancreatic cancer stem cell markers and exosomes - the incentive push.
    Heiler S; Wang Z; Zöller M
    World J Gastroenterol; 2016 Jul; 22(26):5971-6007. PubMed ID: 27468191
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Nuclear receptors in pancreatic tumor cells.
    Damaskos C; Garmpis N; Karatzas T; Kostakis ID; Nikolidakis L; Kostakis A; Kouraklis G
    Anticancer Res; 2014 Dec; 34(12):6897-911. PubMed ID: 25503115
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. diagnosis of postoperative pancreatic fistula.
    Facy O; Chalumeau C; Poussier M; Binquet C; Rat P; Ortega-Deballon P
    Br J Surg; 2012 Aug; 99(8):1072-5. PubMed ID: 22539219
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The molecular mechanisms of traditional Chinese medicine ZHENG syndromes on pancreatic tumor growth.
    Dai HY; Wang P; Feng LY; Liu LM; Meng ZQ; Zhu XY; Wang K; Hua YQ; Mao YX; Chen LY; Chen Z
    Integr Cancer Ther; 2010 Sep; 9(3):291-7. PubMed ID: 20702498
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.